Roggen APO SRL
Roggen APO reported total assets of 68,518 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026).
The score of Roggen APO shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Roggen APO's annual accounts
| 2025 | |
|---|---|
| Net result | 5,071 € |
| Equity | 17,071 € |
| Cash | 25,307 € |
| EBITDA | 5,736 € |
| Total assets | 68,518 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
Roggen APO's financial analysis
- Solvency24.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Roggen APO
Roggen APO's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1010.619.244
- VAT number
- BE1010619244
- Peppol
- Registered · 0208:1010619244 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Jun 2024
- Registered office
- 1702 Dilbeek
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Roggen APO (SRL) has been based in Dilbeek since 2024, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 5,071 € and equity of 17,071 €; its revenue is not published. Its solvency stands at 24.9%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Roggen APO
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Medical Technologies & Systems Wholesale of pharmaceutical and medical goods Houyet · balance sheet 68,801 €
Frequently asked questions about Roggen APO
What is the revenue of Roggen APO?
Roggen APO files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Roggen APO?
In Belgium, the VAT number is the company number prefixed with BE: BE1010619244 for Roggen APO, if the company is VAT-registered. Its company number (CBE) is 1010.619.244.
Where is the registered office of Roggen APO?
According to the CBE register, the registered office of Roggen APO is in 1702 Dilbeek.
What is the equity of Roggen APO?
At the close of the 2025 financial year, the equity of Roggen APO amounts to 17,071 €, a solvency of 24.9% of total assets.
Who manages Roggen APO?
The register lists 1 active mandates at Roggen APO. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Roggen APO
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →